MacroGenics, Inc. (MGNX)
3.58
-0.02
(-0.56%)
USD |
NASDAQ |
Oct 02, 16:00
3.58
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Price : 3.58 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 3.64 | 3.65 | 3.525 | 3.58 | 980531.0 |
| Oct 01, 2026 | 3.85 | 3.88 | 3.585 | 3.60 | 656628.0 |
| Sep 30, 2026 | 3.76 | 3.91 | 3.73 | 3.86 | 634058.0 |
| Sep 29, 2026 | 4.08 | 4.09 | 3.75 | 3.77 | 616435.0 |
| Sep 28, 2026 | 3.73 | 4.11 | 3.69 | 4.06 | 1.913M |
| Sep 25, 2026 | 3.79 | 3.86 | 3.72 | 3.74 | 604617.0 |
| Sep 24, 2026 | 3.80 | 3.87 | 3.62 | 3.80 | 571448.0 |
| Sep 23, 2026 | 4.12 | 4.12 | 3.78 | 3.80 | 524592.0 |
| Sep 22, 2026 | 4.17 | 4.20 | 4.075 | 4.12 | 377359.0 |
| Sep 21, 2026 | 4.16 | 4.185 | 4.08 | 4.12 | 310497.0 |
| Sep 18, 2026 | 4.12 | 4.165 | 4.09 | 4.14 | 873940.0 |
| Sep 17, 2026 | 4.15 | 4.18 | 4.03 | 4.13 | 438002.0 |
| Sep 16, 2026 | 4.05 | 4.10 | 3.98 | 4.08 | 315679.0 |
| Sep 15, 2026 | 4.19 | 4.19 | 3.99 | 4.04 | 264980.0 |
| Sep 14, 2026 | 4.00 | 4.215 | 3.99 | 4.20 | 431465.0 |
| Sep 11, 2026 | 4.02 | 4.09 | 3.91 | 4.00 | 381933.0 |
| Sep 10, 2026 | 4.08 | 4.115 | 3.90 | 3.97 | 434784.0 |
| Sep 09, 2026 | 4.29 | 4.295 | 4.03 | 4.11 | 599226.0 |
| Sep 08, 2026 | 4.29 | 4.43 | 4.11 | 4.32 | 419588.0 |
| Sep 04, 2026 | 4.20 | 4.49 | 4.175 | 4.40 | 442786.0 |
| Sep 03, 2026 | 4.29 | 4.320 | 4.145 | 4.25 | 478600.0 |
| Sep 02, 2026 | 4.05 | 4.37 | 4.045 | 4.32 | 581704.0 |
| Sep 01, 2026 | 3.98 | 4.095 | 3.89 | 4.04 | 499895.0 |
| Aug 31, 2026 | 4.12 | 4.13 | 3.92 | 3.99 | 542802.0 |
| Aug 28, 2026 | 4.06 | 4.15 | 3.975 | 4.13 | 541659.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 144.74 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
Price Related Metrics
| PS Ratio | 1.354 |
| Price to Book Value | 5.315 |
| Earnings Yield | -6.44% |
| Market Cap | 227.85M |